Virology is a branch of microbiology or pathology that studies viral illnesses and viruses, including their biochemistry, distribution, physiology, disease-causing qualities, ecology, molecular biology, evolution, cultivation, genetics, and clinical aspects. Virology describes the way viruses interact with the immunology and physiology of their hosts, the illnesses they cause, how to isolate and grow them, how to infect and exploit host cells for reproduction, and how to employ them in study and therapy.
A key element driving the demand for better virology specimen collection is the increased prevalence of viral infections such as AIDS, SARS-CoV-2, Zika virus, EBOLA, flu, and STDs. According to the World Health Organization (July 2021), by the end of 2020, there were an anticipated 37.7 million (30.2-45.1 million) persons living with the Human immunodeficiency virus, with almost two-thirds of them (25.4 million) residing in the WHO African Region. In 2020, 680,000 individuals will have died from HIV-related causes, while 1.5 million (1.0-2.0 million) will have contracted the virus. In addition, the WHO estimates that 7 million new syphilis infections will occur globally in 2020 (July 2021). This is projected to fuel the market for virology specimen gathering even further.
The epidemics of Babesia and Zika, as well as announcements that they would be included in virology specimen collecting tests, highlight the need for new virology samples technologies, equipment, and consumables. Other governments have launched their own efforts to monitor new and emerging illnesses. The prevalence of malaria in African countries, as well as the risk of Zika virus transmission via mosquitos, has resulted in regulations for Zika virus screening across the region.
North America, Europe, Asia Pacific, and the Rest of the World are the five key areas that make up the worldwide virology specimen collecting market. The greatest geographic market for virology specimen collecting was North America. North America’s considerable position in this market can be ascribed to rising NAT usage (because of the high incidence of TTIs) and technical advancements such as portable diagnostics.
The key players include Dickinson and Company, Becton, Thermo Fisher Scientific Inc., Quidel Corporation, Titan Biotech Ltd., Trinity Biotech, Vircell S.L., Diasorin SA, Puritan Medical Products Co., Copan Italia S.P, and Hardy Diagnostics.
Global Information, Inc. (JASDAQ 4171) www.giiresearch.com Toll Free (US): +1-866-353-3335 Outside US: +1-860-674-8796 Europe (Belgium): +32-2-535-7543 Email: [email protected]